BIO-TECHNE Corp SEC filings TECH
BIO-TECHNE Corp has 1,001 filings in SEC EDGAR's recent list, going back to Feb 14, 2008. Its latest annual report, Form 10-K, was filed on Aug 24, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 6, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 4, 2026 | Nov 3, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Nov 1, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Nov 1, 2026 |
| 4/A | Amended statement of changes in beneficial ownership of securities | Nov 2, 2026 | Aug 15, 2026 |
| 4/A | Amended statement of changes in beneficial ownership of securities | Nov 2, 2026 | Aug 15, 2026 |
| 4/A | Amended statement of changes in beneficial ownership of securities | Nov 2, 2026 | Aug 15, 2026 |
| 4/A | Amended statement of changes in beneficial ownership of securities | Nov 2, 2026 | Aug 15, 2026 |
| 4 | Insider transaction | Nov 2, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Nov 2, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Nov 2, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Nov 2, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Nov 2, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Nov 2, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Nov 2, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Nov 2, 2026 | Oct 29, 2026 |
| 10-K/A | Amended annual report | Oct 28, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Sep 30, 2026 | Sep 28, 2026 |
| 4 | Insider transaction | Sep 24, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Sep 23, 2026 | Sep 23, 2026 |
| DEFA14A | Additional proxy material | Sep 14, 2026 | — |
| 8-K |
Current report
Other events
|
Sep 14, 2026 | Sep 14, 2026 |
| DEFA14A | Additional proxy material | Sep 9, 2026 | — |
| DEFA14A | Additional proxy material | Sep 2, 2026 | — |
| DEFA14A | Additional proxy material | Aug 25, 2026 | — |
| 10-K | Annual report | Aug 24, 2026 | Jun 30, 2026 |
| DEFM14A | Filing | Aug 20, 2026 | — |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 15, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 15, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 15, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 15, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 15, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 15, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2026 | Aug 12, 2026 |
| PREM14A | Filing | Aug 10, 2026 | Aug 10, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2026 | — |
| 4 | Insider transaction | Jul 31, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 28, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 23, 2026 |
| DEFA14A | Additional proxy material | Jul 9, 2026 | — |
| 8-K |
Current report
Material agreement, Officer or director change
|
Jun 26, 2026 | Jun 23, 2026 |
| DEFA14A | Additional proxy material | Jun 25, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 25, 2026 | Jun 25, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 2, 2026 |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2026 | — |
| 4 | Insider transaction | May 12, 2026 | May 8, 2026 |
| 144 | Notice of proposed sale | May 8, 2026 | — |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 6, 2026 | — |
| 8-K |
Current report
Results of operations, Other events
|
May 6, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 1, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2026 | — |
| 4 | Insider transaction | Apr 24, 2026 | Apr 22, 2026 |
| 4 | Insider transaction | Apr 24, 2026 | Apr 22, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 14, 2026 |
| 4 | Insider transaction | Apr 7, 2026 | Apr 3, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 3 | Initial insider ownership | Mar 4, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 144 | Notice of proposed sale | Feb 17, 2026 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 10-Q | Quarterly report | Feb 4, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 4, 2026 | Feb 4, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 4 | Insider transaction | Nov 5, 2025 | Nov 3, 2025 |
| 4 | Insider transaction | Nov 5, 2025 | Nov 3, 2025 |
| 4 | Insider transaction | Nov 5, 2025 | Nov 3, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Shareholder vote results, Other events
|
Nov 5, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 30, 2025 |
| ARS | Annual report to shareholders | Sep 19, 2025 | Jun 30, 2025 |
| DEFA14A | Additional proxy material | Sep 19, 2025 | — |
| DEF 14A | Proxy statement | Sep 19, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Aug 27, 2025 | Aug 25, 2025 |
| 4 | Insider transaction | Aug 27, 2025 | Aug 25, 2025 |
| 144 | Notice of proposed sale | Aug 25, 2025 | — |
| 144 | Notice of proposed sale | Aug 25, 2025 | — |
| 10-K | Annual report | Aug 22, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 4 | Insider transaction | Aug 11, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 6, 2025 | Aug 6, 2025 |
| 4 | Insider transaction | Jul 31, 2025 | Jul 29, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 17, 2025 | Jul 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 16, 2025 | — |
| 4 | Insider transaction | Jun 11, 2025 | Jun 9, 2025 |
| 144 | Notice of proposed sale | Jun 9, 2025 | — |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 6, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 5, 2025 | May 1, 2025 |
| 4/A | Amended statement of changes in beneficial ownership of securities | Apr 11, 2025 | Jul 1, 2019 |
| 4 | Insider transaction | Apr 7, 2025 | Apr 3, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 14, 2025 |
| 144 | Notice of proposed sale | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 7, 2025 | Feb 3, 2025 |
| 3 | Initial insider ownership | Feb 7, 2025 | Feb 1, 2025 |
| 10-Q | Quarterly report | Feb 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change, Other events
|
Feb 5, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4/A | Amended statement of changes in beneficial ownership of securities | Feb 3, 2025 | Aug 15, 2024 |
| 4 | Insider transaction | Jan 29, 2025 | Jan 27, 2025 |
| 144 | Notice of proposed sale | Jan 27, 2025 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| 4 | Insider transaction | Nov 5, 2024 | Nov 1, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 1, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 5, 2024 | Oct 30, 2024 |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Shareholder vote results, Other events
|
Oct 30, 2024 | Oct 25, 2024 |
| 4 | Insider transaction | Oct 28, 2024 | Oct 24, 2024 |
| 4 | Insider transaction | Oct 28, 2024 | Oct 24, 2024 |
| 4 | Insider transaction | Oct 28, 2024 | Oct 24, 2024 |
| 4 | Insider transaction | Oct 28, 2024 | Oct 24, 2024 |
| 4 | Insider transaction | Oct 28, 2024 | Oct 24, 2024 |
| 4 | Insider transaction | Oct 28, 2024 | Oct 24, 2024 |
| 4 | Insider transaction | Oct 28, 2024 | Oct 24, 2024 |
| 4 | Insider transaction | Oct 28, 2024 | Oct 24, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 21, 2024 | — |
| 4 | Insider transaction | Sep 16, 2024 | Sep 12, 2024 |
| ARS | Annual report to shareholders | Sep 12, 2024 | Jun 30, 2024 |
| DEFA14A | Additional proxy material | Sep 12, 2024 | — |
| DEF 14A | Proxy statement | Sep 12, 2024 | Oct 24, 2024 |
| 4 | Insider transaction | Sep 3, 2024 | Aug 29, 2024 |
| 10-K | Annual report | Aug 22, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Aug 19, 2024 | Aug 15, 2024 |
| 4 | Insider transaction | Aug 19, 2024 | Aug 15, 2024 |
| 4 | Insider transaction | Aug 19, 2024 | Aug 15, 2024 |
| 4 | Insider transaction | Aug 19, 2024 | Aug 15, 2024 |
| 4 | Insider transaction | Aug 19, 2024 | Aug 15, 2024 |
| 4 | Insider transaction | Aug 12, 2024 | Aug 8, 2024 |
| 144 | Notice of proposed sale | Aug 8, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Aug 7, 2024 | Aug 7, 2024 |
| 4 | Insider transaction | Aug 6, 2024 | Aug 2, 2024 |
| 4 | Insider transaction | Aug 2, 2024 | Jul 31, 2024 |
| 4 | Insider transaction | Jul 25, 2024 | Jul 23, 2024 |
| 4 | Insider transaction | Jul 10, 2024 | Jul 8, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2024 | — |
| 4 | Insider transaction | May 16, 2024 | May 14, 2024 |
| 144 | Notice of proposed sale | May 14, 2024 | — |
| 10-Q | Quarterly report | May 6, 2024 | Mar 31, 2024 |
| 4 | Insider transaction | May 3, 2024 | May 1, 2024 |
| 3 | Initial insider ownership | May 3, 2024 | Apr 24, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
May 1, 2024 | May 1, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 30, 2024 | Apr 24, 2024 |
| 4 | Insider transaction | Apr 5, 2024 | Apr 3, 2024 |
| 4 | Insider transaction | Mar 11, 2024 | Mar 7, 2024 |
| 144 | Notice of proposed sale | Mar 7, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 10-Q | Quarterly report | Feb 7, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 3 | Initial insider ownership | Feb 5, 2024 | Jan 8, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Nov 1, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 1, 2024 | Feb 1, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 24, 2024 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 8, 2024 | Jan 5, 2024 |
| 4 | Insider transaction | Dec 21, 2023 | Dec 19, 2023 |
| 4/A | Amended statement of changes in beneficial ownership of securities | Dec 14, 2023 | Aug 15, 2023 |
| 4/A | Amended statement of changes in beneficial ownership of securities | Dec 14, 2023 | Aug 15, 2023 |
| 4/A | Amended statement of changes in beneficial ownership of securities | Dec 14, 2023 | Aug 15, 2023 |
| 4/A | Amended statement of changes in beneficial ownership of securities | Dec 14, 2023 | Aug 15, 2023 |
| 4/A | Amended statement of changes in beneficial ownership of securities | Nov 9, 2023 | Nov 1, 2023 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 4 | Insider transaction | Nov 3, 2023 | Nov 1, 2023 |
| 4 | Insider transaction | Nov 3, 2023 | Nov 1, 2023 |
| 4 | Insider transaction | Nov 3, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Results of operations, Shareholder vote results, Other events
|
Oct 31, 2023 | Oct 26, 2023 |
| 4 | Insider transaction | Oct 30, 2023 | Oct 26, 2023 |
| 4 | Insider transaction | Oct 30, 2023 | Oct 26, 2023 |
| 4 | Insider transaction | Oct 30, 2023 | Oct 26, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TECH (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- MN
- Headquarters
- Minneapolis, MN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 842023
- Former names
- TECHNE CORP /MN/ (until Oct 28, 2014)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.